Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2022
Apr. 30, 2021
Current assets:    
Cash and cash equivalents $ 864,363 $ 400,814
Restricted cash 3,928 2,894
Accounts receivable, net of allowance for credit losses of $2,729 and $2,344 as of January 31, 2022 and April 30, 2021, respectively 146,218 160,415
Deferred contract acquisition costs 38,938 36,089
Prepaid expenses and other current assets 39,405 37,002
Total current assets 1,092,852 637,214
Property and equipment, net 6,739 8,881
Goodwill 304,155 198,851
Operating lease right-of-use assets 21,454 25,464
Intangible assets, net 49,948 36,286
Deferred contract acquisition costs, non-current 62,980 50,263
Deferred tax assets 3,765 3,697
Other assets 17,403 12,516
Total assets 1,559,296 973,172
Current liabilities:    
Accounts payable 21,792 7,248
Accrued expenses and other liabilities 42,110 28,909
Accrued compensation and benefits 56,181 52,525
Operating lease liabilities 8,983 8,528
Deferred revenue 362,287 352,805
Total current liabilities 491,353 450,015
Deferred revenue, non-current 33,395 44,895
Net carrying amount 566,271 0
Operating lease liabilities, non-current 14,879 19,649
Other liabilities, non-current 21,089 7,782
Total liabilities 1,126,987 522,341
Commitments and contingencies (Note 8 and 9)
Shareholders’ equity:    
Convertible preference shares, €0.01 par value; 165,000,000 shares authorized, 0 shares issued and outstanding as of January 31, 2022 and April 30, 2021 0 0
Ordinary shares, par value €0.01 per share: 165,000,000 shares authorized; 93,420,927 and 90,533,985 shares issued and outstanding as of January 31, 2022 and April 30, 2021, respectively 982 948
Treasury stock (369) (369)
Additional paid-in capital 1,197,570 1,071,675
Accumulated other comprehensive loss (14,318) (8,105)
Accumulated deficit (751,556) (613,318)
Total shareholders’ equity 432,309 450,831
Total liabilities and shareholders’ equity $ 1,559,296 $ 973,172